抗凝固剂的全球市场调查报告-产业分析，规模，占有率，成长，趋势，2022年～2028年前的预测

Value Market Research深入调查抗凝固剂的全球市场，并预测未来几年行业将出现显着增长。本研究报告提供全球抗凝固剂市场相关之完全产业分析，提供市场规模、市场占有率、增长趋势、2023年至2028年的预测等。该报告以详细的市场介绍和突出报告关键增长数据的执行摘要为首。接续的章节讨论市场价值链、波特五力模型和市场吸引力分析。同时还设立关于COVID-19影响分析的独立章节，以了解市场如何应对疫情。

本报告的市场动态部分详细介绍了当前的市场推动因素/阻碍、课题/风险和未来机遇。本节对企业战略家和新产品开发部门非常有用。抗凝固剂全球市场调查将市场细分化，并根据收益和/或销售额的视点提供市场规模。该数据地区细分，同时国家/地区细分。数据是通过深入的初级访谈和世界各地的行业专家收集而来。详细的调查方法可以在样本报告中找到。这些市场预测受到最新的社会、政治和经济变化以及影响该抗凝固剂市场的当前市场动态所影响。

抗凝固剂市场报告的子章节提供市场竞争力调查，提供一些领先的市场参与者/製造商简介。这些章节涵括可深入了解竞争对手的产品线、财务状况、最新发展以及在行业中拥有最高市场占有率公司所需的丰富资讯。

本报告的观察对象国家如下列。

北美:美国，加拿大，墨西哥

欧洲:英国，德国，法国，义大利，俄罗斯，西班牙，其他的欧洲地区

亚太地区:中国，印度，日本，韩国，澳洲，其他APAC的各国

南美:巴西，阿根廷，秘鲁，智利及其他的南美各国

中东·非洲地区:沙乌地阿拉伯，UAE，以色列，南非

本报告的市场区隔如下列。

各药物类别

NOACs

肝素和LMWH

维他命K拮抗剂

其他

各给药途径

注射用抗凝固剂

口服抗凝固剂

各用途

中风

心房颤动

肺动脉栓塞(PE)

深部静脉血栓症(DVT)

其他

目录

第1章 序文

• 本报告的内容
  • 目的
  • 主要读者
  • 独特的销售主张(USP)和报价环
• 调查范围
• 调查手法
  • 市场调查流程
  • 市场调查手法

第2章 摘要整理

• 抗凝固剂市场概况
• 抗凝固剂的全球市场概述

第3章 抗凝固剂:产业分析

• 简介
• 抗凝固剂市场推动市场要素
• 抗凝固剂市场阻碍市场要素
• 抗凝固剂市场机会
• 抗凝固剂市场趋势
• 抗凝固剂市场波特五力分析
• 抗凝固剂市场魅力度分析
  • 各药物类别市场魅力分析
  • 各给药途径的市场魅力分析
  • 各用途市场魅力分析
  • 各地区市场魅力分析

第4章 价值链分析

• 抗凝固剂的价值链分析
• 抗凝固剂原料的分析
  • 原料的清单
  • 抗凝固剂原料的製造原清单
  • 抗凝固剂主要原料的价格趋势
• 潜在的买主清单
• 行销流通管道
  • 直销
  • 间接行销
  • 行销流通管道的新兴国家市场开拓趋势

第5章 抗凝固剂的全球市场分析:各药物类别

• 各药物类别概要
• 抗凝固剂的全球市场分析:各治疗分类
• NOACs的各地区市场分析
• 肝素·LMWH的各地区市场分析
• 维他命K拮抗剂的各地区市场分析
• 各地区其他市场分析

第6章 抗凝固剂的全球市场分析:各给药途径

• 各给药途径概要
• 抗凝固剂的全球市场分析:各给药途径
• 注射用抗凝固剂的各地区市场分析
• 口服用抗凝固剂的各地区市场分析

第7章 抗凝固剂的全球市场分析:各用途

• 各用途概要
• 抗凝固剂的全球市场分析:各用途概要
• 中风的各地区市场分析
• 心房颤动的各地区市场分析
• 肺动脉栓塞(PE)的各地区市场分析
• 深部静脉血栓症(DVT)的各地区市场分析
• 各地区其他市场分析

第8章 抗凝固剂的全球市场分析:各地区

• 各地区展望
• 简介
• 北美
  • 概要
  • 北美的抗凝固剂市场估计:各国
  • 美国
  • 其他北美地区
• 欧洲
  • 概要
  • 欧洲的抗凝固剂市场区隔估计
  • 欧洲的抗凝固剂市场估计:各国
  • 英国
  • 法国
  • 德国
  • 其他的欧洲地区
• 亚太地区
  • 概要
  • 亚太地区的抗凝固剂市场区隔估计
  • 亚太地区的抗凝固剂的市场估计:各国
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 南美
  • 概要
  • 南美的抗凝固剂市场区隔估计
  • 南美的抗凝固剂的市场估计:各国
  • 巴西
  • 其他南美国家地区
• 中东·非洲地区
  • 概要
  • 中东·非洲的抗凝固剂市场区隔估计
  • 中东·非洲的各国抗凝固剂的市场估计:各国
  • 中东地区
  • 非洲

第9章 抗凝固剂企业的竞争情形

• 抗凝固剂市场竞争形势
• 伙伴关係/合作/协定
• 合併·收购
• 新产品的上市
• 其他的开发

第10章 企业简介

• 企业占有率分析
• 市场集中度
• Bayer AG
  • 企业概要
  • 产品介绍
  • 最近的开发情形
• Aspen Holdings
  • 公司概要
  • 产品介绍
  • 最近的开发情形
• Boehringer Ingelheim GmbH
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Daiichi Sankyo Company, Limited
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Bristol-Myers Squibb Company
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• GlaxoSmithKline
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Pfizer, Inc.
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Sanofi S.A.
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Johnson & Johnson
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Portola Pharmaceuticals, Inc.
  • 公司概要
  • 产品资讯
  • 最新资讯

在公司简介中，财务细节和最近的发展基于可取得的现有信息，可能不包含非上市公司。

Value Market Research deeply researched the Global Anticoagulant Market to foresee a significant growth in the industry over the upcoming years. The global anticoagulant market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global anticoagulant market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this anticoagulant market.

The next sections of the anticoagulant market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America: United States, Canada, and Mexico

Europe: United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific: China, India, Japan, South Korea, Australia & Rest of APAC

Latin America: Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa: Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below:

By Drug Class

NOACs

Heparin & LMWH

Vitamin K Antagonist

Others

By Route Of Administration

Injectable Anticoagulant

Oral Anticoagulant

By Application

Stroke

Atrial Fibrillation

Pulmonary Embolism (PE)

Deep Vein Thrombosis (DVT)

Others

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Anticoagulant Market
• 2.2. Global Anticoagulant Market Snapshot

3 . ANTICOAGULANT - INDUSTRY ANALYSIS

• 3.1. Introduction
• 3.2. Market Drivers of Anticoagulant Market
• 3.3. Market Restraints of Anticoagulant Market
• 3.4. Opportunities of Anticoagulant Market
• 3.5. Trends of Anticoagulant Market
• 3.6. Porter's Five Force Analysis of Anticoagulant Market
• 3.7. Anticoagulant Market Attractiveness Analysis
  • 3.7.1 Market Attractive Analysis by Drug Class
  • 3.7.2 Market Attractive Analysis by Route Of Administration
  • 3.7.3 Market Attractive Analysis by Application
  • 3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Anticoagulant Value Chain Analysis
• 4.2. Anticoagulant Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Anticoagulant Raw Material Manufactures List
  • 4.2.3. Price Trend of Anticoagulant Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ANTICOAGULANT MARKET ANALYSIS BY DRUG CLASS

• 5.1 Overview by Drug Class
• 5.2 Global Anticoagulant Market Analysis by Drug Class
• 5.3 Market Analysis of NOACs by Regions
• 5.4 Market Analysis of Heparin & LMWH by Regions
• 5.5 Market Analysis of Vitamin K Antagonist by Regions
• 5.6 Market Analysis of Others by Regions

6 . GLOBAL ANTICOAGULANT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

• 6.1 Overview by Route Of Administration
• 6.2 Global Anticoagulant Market Analysis by Route Of Administration
• 6.3 Market Analysis of Injectable Anticoagulant by Regions
• 6.4 Market Analysis of Oral Anticoagulant by Regions

7 . GLOBAL ANTICOAGULANT MARKET ANALYSIS BY APPLICATION

• 7.1 Overview by Application
• 7.2 Global Anticoagulant Market Analysis by Application
• 7.3 Market Analysis of Stroke by Regions
• 7.4 Market Analysis of Atrial Fibrillation by Regions
• 7.5 Market Analysis of Pulmonary Embolism (PE) by Regions
• 7.6 Market Analysis of Deep Vein Thrombosis (DVT) by Regions
• 7.7 Market Analysis of Others by Regions

8 . GLOBAL ANTICOAGULANT MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America
  • 8.3.1. Overview
  • 8.3.2. North America Anticoagulant Market Estimate by Country
  • 8.3.3. United State
  • 8.3.4. Rest of North America
• 8.4. Europe
  • 8.4.1. Overview
  • 8.4.2. Europe Anticoagulant Market Estimate by Market Segment
  • 8.4.3. Europe Anticoagulant Market Estimate by Country
  • 8.4.4. United Kingdom
  • 8.4.5. France
  • 8.4.6. Germany
  • 8.4.7 Rest of Europe
• 8.5. Asia Pacific
  • 8.5.1. Overview
  • 8.5.2. Asia Pacific Anticoagulant Market Estimate by Market Segment
  • 8.5.3. Asia Pacific Anticoagulant Market Estimate by Country
  • 8.5.4. China
  • 8.5.5. Japan
  • 8.5.6. India
  • 8.5.7. Rest of Asia Pacific
• 8.6. Latin America
  • 8.6.1. Overview
  • 8.6.2. Latin America Anticoagulant Market Estimate by Market Segment
  • 8.6.3. Latin America Anticoagulant Market Estimate by Country
  • 8.6.4. Brazil
  • 8.6.5. Rest of Latin America
• 8.7. Middle East & Africa
  • 8.7.1. Overview
  • 8.7.2. Middle East & Africa Anticoagulant Market Estimate by Market Segment
  • 8.7.3. Middle East & Africa Anticoagulant Market Estimate by Country
  • 8.7.4. Middle East
  • 8.7.5. Africa

9 . COMPETITIVE LANDSCAPE OF THE ANTICOAGULANT COMPANIES

• 9.1. Anticoagulant Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF ANTICOAGULANT INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Bayer AG
  • 10.3.1. Company Overview
  • 10.3.2. Financials
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Aspen Holdings
  • 10.4.1. Company Overview
  • 10.4.2. Financials
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Boehringer Ingelheim GmbH
  • 10.5.1. Company Overview
  • 10.5.2. Financials
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Daiichi Sankyo Company, Limited
  • 10.6.1. Company Overview
  • 10.6.2. Financials
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Bristol-Myers Squibb Company
  • 10.7.1. Company Overview
  • 10.7.2. Financials
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. GlaxoSmithKline
  • 10.8.1. Company Overview
  • 10.8.2. Financials
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Pfizer, Inc.
  • 10.9.1. Company Overview
  • 10.9.2. Financials
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Sanofi S.A.
  • 10.10.1. Company Overview
  • 10.10.2. Financials
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. Johnson & Johnson
  • 10.11.1. Company Overview
  • 10.11.2. Financials
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. Portola Pharmaceuticals, Inc.
  • 10.12.1. Company Overview
  • 10.12.2. Financials
  • 10.12.3. Products
  • 10.12.4. Recent Developments

Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Global Anticoagulant Market Snapshot
• Drivers of The Global Anticoagulant Market Impact Analysis
• Restraints of The Global Anticoagulant Market Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Global Anticoagulant Market Analysis by Drug Class (USD MN)
• Global Anticoagulant Market Analysis in NOACs by Geography (USD MN)
• Global Anticoagulant Market Analysis in Heparin & LMWH by Geography (USD MN)
• Global Anticoagulant Market Analysis in Vitamin K Antagonist by Geography (USD MN)
• Global Anticoagulant Market Analysis in Others by Geography (USD MN)
• Global Anticoagulant Market Analysis by Route Of Administration (USD MN)
• Global Anticoagulant Market Analysis in Injectable Anticoagulant by Geography (USD MN)
• Global Anticoagulant Market Analysis in Oral Anticoagulant by Geography (USD MN)
• Global Anticoagulant Market Analysis by Application (USD MN)
• Global Anticoagulant Market Analysis in Stroke by Geography (USD MN)
• Global Anticoagulant Market Analysis in Atrial Fibrillation by Geography (USD MN)
• Global Anticoagulant Market Analysis in Pulmonary Embolism (PE) by Geography (USD MN)
• Global Anticoagulant Market Analysis in Deep Vein Thrombosis (DVT) by Geography (USD MN)
• Global Anticoagulant Market Analysis in Others by Geography (USD MN)
• Global Anticoagulant Market by Geography (USD MN)
• North America Anticoagulant Market Analysis by Drug Class (USD MN)
• North America Anticoagulant Market Estimate by Route Of Administration (USD MN)
• North America Anticoagulant Market Estimate by Application (USD MN)
• North America Anticoagulant Market Estimate by Country (USD MN)
• United State Anticoagulant Market Analysis by Drug Class (USD MN)
• United State Anticoagulant Market Estimate by Route Of Administration (USD MN)
• United State Anticoagulant Market Analysis by Application (USD MN)
• Rest of North America Anticoagulant Market Analysis by Drug Class (USD MN)
• Rest of North America Anticoagulant Market Estimate by Route Of Administration (USD MN)
• Rest of North America Anticoagulant Market Estimate by Application(USD MN)
• Europe Anticoagulant Market Analysis by Drug Class (USD MN)
• Europe Anticoagulant Market Estimate by Route Of Administration (USD MN)
• Europe Anticoagulant Market Estimate by Application (USD MN)
• United Kingdom Anticoagulant Market Analysis by Drug Class (USD MN)
• United Kingdom Anticoagulant Market Estimate by Route Of Administration (USD MN)
• United Kingdom Anticoagulant Market Estimate by Application (USD MN)
• France Anticoagulant Market Analysis by Drug Class (USD MN)
• France Anticoagulant Market Estimate by Route Of Administration (USD MN)
• France Anticoagulant Market Estimate by Application (USD MN)
• Germany Anticoagulant Market Analysis by Drug Class (USD MN)
• Germany Anticoagulant Market Estimate by Route Of Administration (USD MN)
• Germany Anticoagulant Market Estimate by Application (USD MN)
• Rest of Europe Anticoagulant Market Analysis by Drug Class (USD MN)
• Rest of Europe Anticoagulant Market Estimate by Route Of Administration (USD MN)
• Rest of Europe Anticoagulant Market Estimate by Application (USD MN)
• Asia Pacific Anticoagulant Market Analysis by Drug Class (USD MN)
• Asia Pacific Anticoagulant Market Estimate by Route Of Administration (USD MN)
• Asia Pacific Anticoagulant Market Estimate by Application (USD MN)
• Asia Pacific Anticoagulant Market Estimate by Country (USD MN)
• China Anticoagulant Market Analysis by Drug Class (USD MN)
• China Anticoagulant Market Estimate by Route Of Administration (USD MN)
• China Anticoagulant Market Estimate by Application (USD MN)
• Japan Anticoagulant Market Analysis by Drug Class (USD MN)
• Japan Anticoagulant Market Estimate by Route Of Administration (USD MN)
• Japan Anticoagulant Market Estimate by Application (USD MN)
• India Anticoagulant Market Analysis by Drug Class (USD MN)
• India Anticoagulant Market Estimate by Route Of Administration (USD MN)
• India Anticoagulant Market Estimate by Application (USD MN)
• Rest of Asia Pacific Anticoagulant Market Analysis by Drug Class (USD MN)
• Rest of Asia Pacific Anticoagulant Market Estimate by Route Of Administration (USD MN)
• Rest of Asia Pacific Anticoagulant Market Estimate by Application (USD MN)
• Latin America Anticoagulant Market Analysis by Drug Class (USD MN)
• Latin America Anticoagulant Market Estimate by Route Of Administration (USD MN)
• Latin America Anticoagulant Market Estimate by Application (USD MN)
• Latin America Anticoagulant Market Estimate by Country (USD MN)
• Brazil Anticoagulant Market Analysis by Drug Class (USD MN)
• Brazil Anticoagulant Market Estimate by Route Of Administration (USD MN)
• Brazil Anticoagulant Market Estimate by Application (USD MN)
• Rest of Latin America Anticoagulant Market Analysis by Drug Class (USD MN)
• Rest of Latin America Anticoagulant Market Estimate by Route Of Administration (USD MN)
• Rest of Latin America Anticoagulant Market Estimate by Application (USD MN)
• Middle East & Africa Anticoagulant Market Analysis by Drug Class (USD MN)
• Middle East & Africa Anticoagulant Market Estimate by Route Of Administration (USD MN)
• Middle East & Africa Anticoagulant Market Estimate by Application (USD MN)
• Middle East & Africa Anticoagulant Market Estimate by Country (USD MN)
• Middle East Anticoagulant Market Analysis by Drug Class (USD MN)
• Middle East Anticoagulant Market Estimate by Route Of Administration (USD MN)
• Middle East Anticoagulant Market Estimate by Application (USD MN)
• Africa Anticoagulant Market Analysis by Drug Class (USD MN)
• Africa Anticoagulant Market Estimate by Route Of Administration (USD MN)
• Africa Anticoagulant Market Estimate by Application (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisiton
• New Product Launch
• Other Developments
• Company Market Share Analysis

LIST OF FIGURES

• Research Scope of Anticoagulant Report
• Market Research Process
• Market Research Methodology
• Global Anticoagulant Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Drug Class
• Market Attractiveness Analysis by Route Of Administration
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Anticoagulant Market Analysis by Drug Class (USD MN)
• Global Anticoagulant Market Analysis in NOACs by Geography (USD MN)
• Global Anticoagulant Market Analysis in Heparin & LMWH by Geography (USD MN)
• Global Anticoagulant Market Analysis in Vitamin K Antagonist by Geography (USD MN)
• Global Anticoagulant Market Analysis in Others by Geography (USD MN)
• Global Anticoagulant Market Analysis by Route Of Administration (USD MN)
• Global Anticoagulant Market Analysis in Injectable Anticoagulant by Geography (USD MN)
• Global Anticoagulant Market Analysis in Oral Anticoagulant by Geography (USD MN)
• Global Anticoagulant Market Analysis by Application (USD MN)
• Global Anticoagulant Market Analysis in Stroke by Geography (USD MN)
• Global Anticoagulant Market Analysis in Atrial Fibrillation by Geography (USD MN)
• Global Anticoagulant Market Analysis in Pulmonary Embolism (PE) by Geography (USD MN)
• Global Anticoagulant Market Analysis in Deep Vein Thrombosis (DVT) by Geography (USD MN)
• Global Anticoagulant Market Analysis in Others by Geography (USD MN)
• Latin America Anticoagulant Market by Revenue
• Middle East & Africa Anticoagulant Market by Revenue
• Recent Development in Anticoagulant Industry
• Company Market Share Analysis
• Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.